Company’s Position as a Leader and Strategic Partner in Pharmaceutical Cannabinoids Strengthens with Involvement in Seven CBD Clinical Trials. Read More
The post INSYS Therapeutics Reports Third Quarter 2018 Results appeared first on Dagga Magazine.